NovoCure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

CEO

Ashley Cordova

CEOAshley Cordova

Employees

1,488

Employees1,488

Headquarters

St. Helier, Jersey

HeadquartersSt. Helier, Jersey

Founded

2000

Founded2000

Employees

1,488

Employees1,488

NVCR Key Statistics

Market cap

2.07B

Market cap2.07B

Price-Earnings ratio

-12.27

Price-Earnings ratio-12.27

Dividend yield

—

Dividend yield—

Average volume

943.16K

Average volume943.16K

High today

$18.78

High today$18.78

Low today

$17.70

Low today$17.70

Open price

$17.70

Open price$17.70

Volume

847.13K

Volume847.13K

52 Week high

$34.13

52 Week high$34.13

52 Week low

$14.17

52 Week low$14.17

NVCR News

Simply Wall St 1d

Is NovoCure Using Debt Sensibly?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a...

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

People also own

Based on the portfolios of people who own NVCR. This list is generated using Robinhood data, and it’s not a recommendation.